Trisomy 18: Prenatal Diagnosis and Outcome in a Tertiary Care Fetal Medicine Center in South India

Abstract

Edwards' syndrome (trisomy 18) is the second most common aneuploidy known in humans, with an overall incidence of 1 in 6,000 live births. It occurs due to the presence of complete or part of an extra copy of chromosome 18 in all or a few body cells of the affected fetus, and it causes major anomalies in the organ systems. Despite this, an accurate diagnosis is often not made antenatally due to its very varied phenotype and the subtle nature of some of the common and consistent findings associated with this condition. This leads to lapses or delays in cytogenetic confirmation as well as delays in decision regarding termination of pregnancies with this mostly lethal fetal aneuploidy. We describe the prenatal profile of 45 confirmed cases of trisomy 18 at a tertiary fetal medicine unit. The presence of a combination of ultrasound (US) findings described in these cases will help alert sonologists and clinicians to suspect this condition and offer a confirmative cytogenetic test without delay for prenatal diagnosis. This study describes the prenatal diagnostic profile of cytogenetically confirmed trisomy 18 cases in a tertiary fetal medicine center in India. A retrospective analysis of records of 45 prenatally diagnosed trisomy 18 cases at a single tertiary fetal medicine center over a period of 11 years was done. Data were collected to describe maternal demography, indication for evaluation, major and minor US findings (trimester-wise), type of invasive test, and gestational age at diagnosis. Outcomes in terms of pregnancy termination, miscarriage, stillbirth, or livebirth were documented. Presenting at a mean maternal age and gestation age of 31.7 years and 22 + 5 weeks, respectively, 41/45 (91%) fetuses showed major and 40/45 (89%) showed minor US findings with an overall US sensitivity of 100%. The most common major US finding was a cardiac anomaly in 26 (57.8%) patients, while clenched fist with pointing index finger, observed in 17 (37.8%) cases, was the most common minor US finding. Fetal growth restriction (FGR) was noted in 20 (44.4%) patients. After cytogenetic confirmation, 37.8% underwent termination, 17.8% had a fetal demise, and only 11.1% had live birth with the longest survival noted at 5.5 months postnatally. Gender was documented in 13 fetuses with a male-to-female ratio of 0.6. A meticulously performed US examination can detect a combination of anomalies that could alert the sonologist to the possibility of trisomy 18. While the US profile could vary among fetuses, an understanding of the spectrum of the anomalies commonly seen in these fetuses would enable caregivers to reach an early accurate diagnosis, and offer appropriate genetic counseling and pregnancy decisions in these cases.

Keywords

fetal trisomy 18 - cytogenetic analysis - sonographic findings - invasive test - prenatal detection

Ethics Approval

Ethical approval for this study was granted by the Ethics (Medical Research) Committee Office, Amrita Institute of Medical Sciences & Research Center, Cochin, Kerala, India.

Publication History

Article published online:
23 April 2024

• References

• 1 Goldstein H, Nielsen KG. Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark. Clin Genet 1988; 34 (06) 366-372
• 2 Edwards JH, Harnden DG, Cameron AH, Crosse VM, Wolff OH. A new trisomic syndrome. Lancet 1960; 1 (7128) 787-790
• 3 Morris JK, Savva GM. The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A 2008; 146A [phone]
• 4 Won RH, Currier RJ, Lorey F, Towner DR. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn 2005; 25 (07) 608-611
• 5 Irving C, Richmond S, Wren C, Longster C, Embleton ND. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med 2011; 24 (01) 137-141
• 6 Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 1996; 75 (01) F38-F41
• 7 Carey JC. Trisomy 18 and trisomy 13 syndromes. In: Cassidy SB, Allanson JE. eds. Management of Genetic Syndromes. 3rd ed. New York, NY:: John Wiley & Sons;; 2010: 807-823
• 8 Carter PE, Pearn JH, Bell J, Martin N, Anderson NG. Survival in trisomy 18. Life tables for use in genetic counselling and clinical paediatrics. Clin Genet 1985; 27 (01) 59-61
• 9 Young ID, Cook JP, Mehta L. Changing demography of trisomy 18. Arch Dis Child 1986; 61 (10) 1035-1036
• 10 Savva GM, Walker K, Morris JK. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome). Prenat Diagn 2010; 30 (01) 57-64
• 11 Tucker ME, Garringer HJ, Weaver DD. Phenotypic spectrum of mosaic trisomy 18: two new patients, a literature review, and counseling issues. Am J Med Genet A 2007; 143A [phone]
• 12 Geipel A, Willruth A, Vieten J, Gembruch U, Berg C. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester. Ultrasound Obstet Gynecol 2010; 35 (05) 535-539
• 13 Sepulveda W, Wong AE, Dezerega V. First-trimester sonographic findings in trisomy 18: a review of 53 cases. Prenat Diagn 2010; 30 (03) 256-259
• 14 Hill LM. The sonographic detection of trisomies 13, 18, and 21. Clin Obstet Gynecol 1996; 39 (04) 831-850
• 15 Viora E, Zamboni C, Mortara G. et al. Trisomy 18: fetal ultrasound findings at different gestational ages. Am J Med Genet A 2007; 143A [phone]
• 16 Cho RC, Chu P, Smith-Bindman R. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of trisomy 18 based on serum screening. Prenat Diagn 2009; 29 (02) 129-139
• 17 Twining P, Zuccollo J, Clewes J, Swallow J. Fetal choroid plexus cysts: a prospective study and review of the literature. Br J Radiol 1991; 64 (758) 98-102
• 18 Van Dyke DC, Allen M. Clinical management considerations in long-term survivors with trisomy 18. Pediatrics 1990; 85 (05) 753-759
• 19 Niedrist D, Riegel M, Achermann J, Schinzel A. Survival with trisomy 18: data from Switzerland. Am J Med Genet A 2006; 140 (09) 952-959
• 20 Matthews AL. Chromosomal abnormalities: trisomy 18, trisomy 13, deletions, and microdeletions. J Perinat Neonatal Nurs 1999; 13 (02) 59-75 , quiz 103–104
• 21 Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA. Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol 2006; 76 (10) 706-713
• 22 Paris JJ, Weiss AH, Soifer S. Ethical issues in the use of life-prolonging interventions for an infant with trisomy 18. J Perinatol 1992; 12 (04) 366-368
• 23 Baty BJ, Blackburn BL, Carey JC. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994; 49 (02) 175-188
• 24 Calderone JP, Chess J, Borodic G, Albert DM. Intraocular pathology of trisomy 18 (Edwards's syndrome): report of a case and review of the literature. Br J Ophthalmol 1983; 67 (03) 162-169
• 25 Geiser CF, Schindler AM. Long survival in a male with 18-trisomy syndrome and Wilms' tumor. Pediatrics 1969; 44 (01) 111-116
• 26 Karayalcin G, Shanske A, Honigman R. Wilms' tumor in a 13-year-old girl with trisomy 18. Am J Dis Child 1981; 135 (07) 665-666
• 27 Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis 2012; 7: 81
• 28 Jones KL. Smith's Recognizable Patterns of Malformation. 6th ed. Philadelphia, PA:: WB Saunders/Elsevier; 2008
• 29 Bronsteen R, Lee W, Vettraino IM, Huang R, Comstock CH. Second-trimester sonography and trisomy 18. J Ultrasound Med 2004; 23 (02) 233-240
• 30 Yeo L, Guzman ER, Day-Salvatore D, Walters C, Chavez D, Vintzileos AM. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med 2003; 22 (06) 581-590 , quiz 591–592
• 31 Shields LE, Carpenter LA, Smith KM, Nghiem HV. Ultrasonographic diagnosis of trisomy 18: is it practical in the early second trimester?. J Ultrasound Med 1998; 17 (05) 327-331
• 32 Brumfield CG, Wenstrom KD, Owen J, Davis RO. Ultrasound findings and multiple marker screening in trisomy 18. Obstet Gynecol 2000; 95 (01) 51-54
• 33 Dézsi C, Szöllősi A, Sólya K. et al. Implementing the use of ultrasonography screening markers of the trisomy 18 in the clinical practice, in the era of non-invasive prenatal test: case reports. Int J Med Pharm Case Reports 2017; 10: 1-6